phrykt

Cel Sci Corp (CVM): who owns it and who trades it

As of Nov 16, 2026, CVM insiders reported 5 purchases worth $867K in the last 12 months. The largest buyer was Geert R Kersten (CEO), with $867K. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Cel Sci

From the latest filings

Overall: about as much buying as selling. Famous investors mostly sold. Insiders mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, CVM insiders reported $867K of open-market purchases and $0 of sales.

Purchases, 12 months
$867K
5 trades, 1 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Aug 25, 2026
Filed Aug 26, 2026

Purchases and sales by month

$479K$479KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 25, 2026Geert R KerstenCEOPurchase100,000$1.38$138KForm 4
May 14, 2026Geert R KerstenCEOPurchase300,000$1.20$360KForm 4
May 13, 2026Geert R KerstenCEOPurchase100,000$1.19$119KForm 4
Jan 22, 2026Geert R KerstenCEOPurchase38,023$5.26$200KForm 4
Dec 4, 2025Geert R KerstenCEOPurchase8,389$5.96$50KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Geert R KerstenChief Executive Officer, Director$867K–Aug 25, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CVM short interest

Low short interest. 4.0% of CVM shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went up 177%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 705,801 CVM shares were sold short, 4.0% of the shares outstanding, up 6.3% from the report before. At the average daily volume of 118,342 shares, buying them all back would take about 6.0 trading days (days to cover).

Shares short, % of all shares

4.01%May 15Oct 3015.8%

Days to cover

6.0May 15Oct 306.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026705,8014.01%+6%118,3426.0
Oct 15, 2026663,8333.77%+12%412,8051.6
Sep 30, 2026592,4203.37%-4%143,1934.1
Sep 15, 2026619,2623.52%-21%110,3325.6
Aug 31, 2026782,4594.45%+10%152,6935.1
Aug 14, 2026714,4714.06%-40%271,8962.6
Jul 31, 20261.20M14.13%+67%316,8463.8
Jul 15, 2026718,0088.45%+172%399,6801.8
Jun 30, 2026263,5423.10%-66%424,9641.0
Jun 15, 2026765,4849.01%+232%346,0772.2
May 29, 2026230,6792.72%-10%481,4071.0
May 15, 2026255,0313.00%-64%1.29M1.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Cel Sci company events

Cel Sci filed 5 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Aug 17, 2026.

  1. Aug 17, 2026VoteReported shareholder vote results. Filing
  2. Jun 16, 2026AgreementCEL-SCI Corporation, a Colorado corporation, entered into a Placement Agency Agreement with ThinkEquity LLC relating to the sale and issuance of 2,500,000 shares of the Company’s common stock, at an offering price of $1.00 per share. Filing
  3. May 14, 2026AgreementThe Company issued a press release, filed as Exhibit 99, concerning a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialization of Multikine (Leukocyte Interleukin, Injection) in the treatment of head and neck… Filing
  4. May 13, 2026AgreementCEL-SCI Corporation, a Colorado corporation, entered into a Placement Agency Agreement with ThinkEquity LLC relating to the sale and issuance of 6,000,000 shares of the Company’s common stock, at an offering price of $1.20 per share. Filing
  5. Nov 24, 2025SharesChanged the rights of its shareholders. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Cel Sci financials

Famous investors that hold CVM

2 of the 50 well-known investors we track reported holding CVM in their latest 13F filing. The largest position is Jim Simons's, worth $970K.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026470,869$970K0.0%-18%
Ken Griffin · Citadel AdvisorsQ3 2026162,140$334K0.0%-18%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Cel Sci Corp (CVM) stock

Are CVM insiders buying or selling?

In the last 12 months, CVM insiders reported 5 open-market purchases worth $867K and no sales. The latest trade was on Aug 25, 2026. See every trade.

What is the short interest in CVM?

As of Oct 30, 2026, 705,801 CVM shares were sold short, 4.0% of the shares outstanding, up 6.3% from the report before. At the average daily volume of 118,342 shares, buying them all back would take about 6.0 trading days (days to cover). See the history.

Which famous investors hold CVM?

2 of the 50 well-known investors we track reported CVM in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $970K. See all holders.

Executive pay

Cel Sci's chief executive was paid a total of $920K for the year ended Dec 31, 2025, down 14% from $1.1M the year before. In the last 12 months, Cel Sci's executives and directors bought $867K of stock on the open market and sold none.

Chief executive, total pay$920KYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$618KThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$397KThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.